RankAlpha logo
Back to Rankings

CRIS

CurisD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
CRIS vs peer average
50/100
CRIS vs. peer average (D vs. D)
Grade spread
A 1 · C 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

VTGN is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $9.6M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerVTGNVistagen Therapeutics
CRIS
Curis
VTGN
Vistagen Therapeutics
Grade
D
F
Momentum
14
7
Value
59
58
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs VTGN

CRIS / VTGN
Grade Position
In line
CRIS vs. peer average (D vs. D)
50/100
Momentum
14
CRIS
Value
59
CRIS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CRIS
1
VTGN
Vistagen Therapeutics Inc Common
F
20/100
+1
2
ASBP
Aspire Biopharma Holdings Inc Common
F
20/100
+1
3
BIVI
BioVie Inc Class A Common
F
20/100
+1
4
PPBT
Purple Biotech Ltd ADR
C
60/100
-1
5
CMMB
Chemomab Therapeutics Ltd ADR
A
100/100
-3
VTGN is the first peer returned for this comparison set.